Page 501 - ACCCN's Critical Care Nursing

478 P R I N C I P L E S A N D P R A C T I C E O F C R I T I C A L C A R E

111. Walgaard C, Lingsma HF, Ruts L, Drenthen J, Van Koningsveld R et al. Predic- 124. Rossetti AO, Oddo M. The neuro-ICU patient and electroencephalography
tion of respiratory insufficiency in Guillain–Barré syndrome. Ann Neurol paroxysms: If and when to treat. Curr Opin Crit Care 2010; 16(2):
2010; 67(6): 781–7. 105–9.
112. Flachenecker P. Autonomic dysfunction in guillain-barré syndrome and mul- 125. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status
tiple sclerosis. J Neurol 2007; 254(2 Supp): 96–101. epilepticus with pentobarbital, propofol, or midazolam: a systematic review.
113. Gregory MA, Gregory RJ, Podd JV. Understanding Guillain–Barré syndrome Epilepsia 2002; 43(2): 146–53.
and central nervous system involvement. Rehabil Nurs 2005; 30(5): 126. Jamrozik K, Dobson A, Hobbs M et al. Monitoring the incidence of cardiovas-
207–12. cular disease in Australia. AIHW cat. no. CVD 16. Cardiovascular Disease
114. Romi F, Gilhus NE, Aarli JA. Myasthenia gravis: clinical, immunological, and Series no. 17.Canberra: AIHW; 2001.
therapeutic advances. Acta Neurol Scand 2005; 111(2): 134–41. 127. Australian Institute of Health and Welfare (AIHW). How we manage stroke in
115. Bershad EM, Feen ES, Suarez JI. Myasthenia gravis crisis. South Med J 2008; Australia. AIHW cat. no. CVD 31.Series S. Canberra: AIHW; 2006.
101(1): 63–9. 128. National Heart Foundation of Australia (National Blood Pressure and Vas-
116. Seneviratne J, Mandrekar J, Wijdicks EFM, Rabinstein AA. Noninvasive ven- cular Disease Advisory Committee). Guide to management of hypertension
tilation in myasthenic crisis. Arch Neurol 2008; 65(1): 54–8. 2008. Updated August 2009. Web version 2009. [Cited April 2011]. Available
117. Kittiwatanapaisan W, Gauthier DK, Williams AM, Oh SJ. Fatigue in myasthe- from: www.heartfoundation.org.au.
nia gravis patients. J Neurosci Nurs 2003; 35(2): 87–93, 106. 129. Fischbein NJ, Wijman CAC. Nontraumatic intracranial hemorrhage. Neuro-
118. Seneviratne J, Mandrekar J, Wijdicks EFM, Rabinstein AA. Predictors of extu- imaging Clin N Am 2010; 20(4): 469–92.
bation failure in myasthenic crisis. Arch Neurol 2008; 65(7): 929–33. 130. Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage. Lancet.
119. Huff JS, Fountain NB. Pathophysiology and definitions of seizures and status 2009; 373(9675): 1632–44.
epilepticus. Emerg Med Clin North Am 2011; 29(1): 1–13. 131. Elliott J, Smith M. The acute management of intracerebral hemorrhage: a
120. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of clinical review. Anesth Analg 2010; 110(5): 1419–27.
status epilepticus. Eur J Neurol 2004; 11(12): 800–10. 132. Tetri S, Juvela S, Saloheimo P, Pyhtinen J, Hillbom M. Hypertension and
121. Marik PE. Seizures and Status Epilepticus. In: Marik, E (ed) Handbook of diabetes as predictors of early death after spontaneous intracerebral hemor-
evidence-based critical care. New York: Springer; 2010. Part 6, p. 503–16. rhage. J Neurosurg 2009; 110(3): 411–17.
122. Bleck TP. Refractory status epilepticus. Curr Opin Crit Care 2005; 11(2): 133. National Stroke Foundation. Clinical Guidelines for Stroke Management 2010.
117–20. Melbourne: National Stroke Foundation; 2010.
123. Shearer P, Riviello J. Generalized convulsive status epilepticus in adults and 134. Interact 2 Clinical trial. [Cited Dec 2010]. Available from:
children: Treatment guidelines and protocols. Emerg Med Clin North Am http://clinicaltrials.gov/ct2/show/NCT00716079?term=NCT00716079&r
2011; 29(1): 51–64. ank=1